Brief: Spago Nanomedical Reports Favorable Data In Breast Cancer Model With Tumorad
April 24 (Reuters) - Spago Nanomedical AB (publ)
SPAGO.ST :
* SPAGO NANOMEDICAL REPORTS FAVORABLE DATA IN BREAST CANCER
MODEL
WITH TUMORAD
Source text for Eikon: ID:nMFN1MzRBl
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose